nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—systemic scleroderma—Nifedipine—hypertension	0.249	1	CpDpCtD
Tolazoline—ADRA2B—hypertension	0.123	0.486	CbGaD
Tolazoline—ADRA1A—hypertension	0.0763	0.301	CbGaD
Tolazoline—Phenacemide—Guanfacine—hypertension	0.0666	0.426	CrCrCtD
Tolazoline—ADRA2A—hypertension	0.054	0.213	CbGaD
Tolazoline—Naphazoline—Propranolol—hypertension	0.0523	0.335	CrCrCtD
Tolazoline—Antazoline—Bepridil—hypertension	0.0373	0.239	CrCrCtD
Tolazoline—ADRA2C—Guanabenz—hypertension	0.0202	0.073	CbGbCtD
Tolazoline—ADRA2B—Guanabenz—hypertension	0.0192	0.0693	CbGbCtD
Tolazoline—ADRA2B—Guanfacine—hypertension	0.0178	0.0644	CbGbCtD
Tolazoline—ADRA2C—Fenoldopam—hypertension	0.016	0.0577	CbGbCtD
Tolazoline—ADRA2B—Fenoldopam—hypertension	0.0151	0.0547	CbGbCtD
Tolazoline—ADRA2A—Methyldopa—hypertension	0.0146	0.0527	CbGbCtD
Tolazoline—ADRA2A—Guanabenz—hypertension	0.0133	0.0482	CbGbCtD
Tolazoline—ADRA2A—Guanfacine—hypertension	0.0124	0.0448	CbGbCtD
Tolazoline—ADRA2B—Prazosin—hypertension	0.0115	0.0415	CbGbCtD
Tolazoline—ADRA1A—Terazosin—hypertension	0.0112	0.0404	CbGbCtD
Tolazoline—ADRA2A—Fenoldopam—hypertension	0.0105	0.0381	CbGbCtD
Tolazoline—ADRA2C—Carvedilol—hypertension	0.0104	0.0378	CbGbCtD
Tolazoline—ADRA1A—Fenoldopam—hypertension	0.0101	0.0365	CbGbCtD
Tolazoline—ADRA2B—Carvedilol—hypertension	0.0099	0.0358	CbGbCtD
Tolazoline—ADRA2A—Doxazosin—hypertension	0.00972	0.0351	CbGbCtD
Tolazoline—ADRA1A—Doxazosin—hypertension	0.00932	0.0337	CbGbCtD
Tolazoline—ADRA2C—Clonidine—hypertension	0.00917	0.0331	CbGbCtD
Tolazoline—ADRA2B—Clonidine—hypertension	0.0087	0.0314	CbGbCtD
Tolazoline—ADRA2A—Prazosin—hypertension	0.00798	0.0289	CbGbCtD
Tolazoline—ADRA1A—Prazosin—hypertension	0.00765	0.0277	CbGbCtD
Tolazoline—ADRA2A—Carvedilol—hypertension	0.00689	0.0249	CbGbCtD
Tolazoline—ADRA1A—Carvedilol—hypertension	0.0066	0.0239	CbGbCtD
Tolazoline—ADRA1A—Nicardipine—hypertension	0.0066	0.0239	CbGbCtD
Tolazoline—ADRA2A—Clonidine—hypertension	0.00605	0.0219	CbGbCtD
Tolazoline—ADRA1A—Clonidine—hypertension	0.0058	0.021	CbGbCtD
Tolazoline—Naphazoline—NISCH—hypertension	0.000416	0.188	CrCbGaD
Tolazoline—HRH2—heart—hypertension	0.000215	0.0598	CbGeAlD
Tolazoline—HRH2—cardiovascular system—hypertension	0.000203	0.0565	CbGeAlD
Tolazoline—Naphazoline—ADRA2B—hypertension	0.000194	0.0879	CrCbGaD
Tolazoline—HRH2—cardiac atrium—hypertension	0.000184	0.0512	CbGeAlD
Tolazoline—Mephentermine—ADRA1A—hypertension	0.000162	0.0732	CrCbGaD
Tolazoline—HRH2—adrenal gland—hypertension	0.00016	0.0447	CbGeAlD
Tolazoline—ADRA2C—cardiac ventricle—hypertension	0.000153	0.0426	CbGeAlD
Tolazoline—ADRA2C—myocardium—hypertension	0.000144	0.0401	CbGeAlD
Tolazoline—Phenelzine—ABAT—hypertension	0.000141	0.0637	CrCbGaD
Tolazoline—HRH2—endocrine gland—hypertension	0.000139	0.0387	CbGeAlD
Tolazoline—HRH2—central nervous system—hypertension	0.000125	0.0349	CbGeAlD
Tolazoline—ADRA1A—brainstem—hypertension	0.000122	0.0339	CbGeAlD
Tolazoline—Naphazoline—ADRA1A—hypertension	0.00012	0.0544	CrCbGaD
Tolazoline—Benzyl alcohol—ALDH2—hypertension	0.000117	0.0531	CrCbGaD
Tolazoline—L-Phenylalanine—TH—hypertension	0.000106	0.048	CrCbGaD
Tolazoline—ADRA2C—nephron tubule—hypertension	0.000106	0.0294	CbGeAlD
Tolazoline—ADRA1A—heart—hypertension	0.000105	0.0293	CbGeAlD
Tolazoline—ADRA2C—adrenal cortex—hypertension	0.000104	0.0289	CbGeAlD
Tolazoline—ADRA2C—heart—hypertension	0.0001	0.028	CbGeAlD
Tolazoline—ADRA1A—cardiovascular system—hypertension	9.95e-05	0.0277	CbGeAlD
Tolazoline—ADRA2C—decidua—hypertension	9.77e-05	0.0272	CbGeAlD
Tolazoline—Phentermine—SLC6A2—hypertension	9.62e-05	0.0435	CrCbGaD
Tolazoline—ADRA2C—kidney—hypertension	9.28e-05	0.0258	CbGeAlD
Tolazoline—Dextroamphetamine—SLC6A2—hypertension	9.18e-05	0.0415	CrCbGaD
Tolazoline—ADRA2C—cortex of kidney—hypertension	9.04e-05	0.0251	CbGeAlD
Tolazoline—ADRA2C—cardiac atrium—hypertension	8.59e-05	0.0239	CbGeAlD
Tolazoline—Naphazoline—ADRA2A—hypertension	8.52e-05	0.0385	CrCbGaD
Tolazoline—ADRA2C—medulla oblongata—hypertension	8.1e-05	0.0225	CbGeAlD
Tolazoline—HRH1—smooth muscle tissue—hypertension	8.1e-05	0.0225	CbGeAlD
Tolazoline—ADRA2A—heart—hypertension	8.02e-05	0.0223	CbGeAlD
Tolazoline—HRH1—decidua—hypertension	7.94e-05	0.0221	CbGeAlD
Tolazoline—ADRA1A—adrenal gland—hypertension	7.87e-05	0.0219	CbGeAlD
Tolazoline—Methamphetamine—ADRA2B—hypertension	7.8e-05	0.0353	CrCbGaD
Tolazoline—ADRA2A—decidua—hypertension	7.8e-05	0.0217	CbGeAlD
Tolazoline—ADRA2C—adrenal gland—hypertension	7.5e-05	0.0209	CbGeAlD
Tolazoline—Amphetamine—SLC6A2—hypertension	7.4e-05	0.0334	CrCbGaD
Tolazoline—ADRA2A—cortex of kidney—hypertension	7.21e-05	0.0201	CbGeAlD
Tolazoline—ADRA2A—cardiac atrium—hypertension	6.86e-05	0.0191	CbGeAlD
Tolazoline—Methamphetamine—SLC6A2—hypertension	6.85e-05	0.031	CrCbGaD
Tolazoline—ADRA1A—endocrine gland—hypertension	6.83e-05	0.019	CbGeAlD
Tolazoline—Dextroamphetamine—ADRA1A—hypertension	6.47e-05	0.0292	CrCbGaD
Tolazoline—ADRA2A—medulla oblongata—hypertension	6.46e-05	0.018	CbGeAlD
Tolazoline—ADRA1A—central nervous system—hypertension	6.15e-05	0.0171	CbGeAlD
Tolazoline—HRH1—adrenal gland—hypertension	6.09e-05	0.017	CbGeAlD
Tolazoline—ADRA2A—adrenal gland—hypertension	5.98e-05	0.0167	CbGeAlD
Tolazoline—ADRA2C—central nervous system—hypertension	5.86e-05	0.0163	CbGeAlD
Tolazoline—HRH1—endocrine gland—hypertension	5.28e-05	0.0147	CbGeAlD
Tolazoline—ADRA2A—endocrine gland—hypertension	5.19e-05	0.0144	CbGeAlD
Tolazoline—Phentermine—SLC6A3—hypertension	4.89e-05	0.0221	CrCbGaD
Tolazoline—HRH1—central nervous system—hypertension	4.76e-05	0.0132	CbGeAlD
Tolazoline—ADRA2A—central nervous system—hypertension	4.68e-05	0.013	CbGeAlD
Tolazoline—Dextroamphetamine—SLC6A3—hypertension	4.67e-05	0.0211	CrCbGaD
Tolazoline—Phenelzine—CYP3A5—hypertension	4.16e-05	0.0188	CrCbGaD
Tolazoline—Amphetamine—SLC6A3—hypertension	3.76e-05	0.017	CrCbGaD
Tolazoline—Phentermine—SLC6A4—hypertension	3.66e-05	0.0165	CrCbGaD
Tolazoline—Methamphetamine—SLC6A3—hypertension	3.49e-05	0.0158	CrCbGaD
Tolazoline—Methamphetamine—ADRA2A—hypertension	3.42e-05	0.0155	CrCbGaD
Tolazoline—Benzyl alcohol—CYP1A1—hypertension	3.33e-05	0.0151	CrCbGaD
Tolazoline—Amphetamine—SLC6A4—hypertension	2.81e-05	0.0127	CrCbGaD
Tolazoline—Amphetamine—DRD2—hypertension	2.8e-05	0.0127	CrCbGaD
Tolazoline—Methamphetamine—SLC6A4—hypertension	2.61e-05	0.0118	CrCbGaD
Tolazoline—ADRA2C—Signaling Pathways—KDR—hypertension	1.41e-06	2.42e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCR5—hypertension	1.41e-06	2.42e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PRKCD—hypertension	1.41e-06	2.42e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—TP53—hypertension	1.41e-06	2.41e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CALM1—hypertension	1.4e-06	2.41e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—APOE—hypertension	1.4e-06	2.4e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—LPL—hypertension	1.39e-06	2.39e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CAV1—hypertension	1.39e-06	2.38e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—H2AFX—hypertension	1.38e-06	2.37e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PRKCD—hypertension	1.38e-06	2.37e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCR5—hypertension	1.38e-06	2.37e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RPS6KB1—hypertension	1.38e-06	2.37e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PDGFRB—hypertension	1.38e-06	2.37e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—APOA1—hypertension	1.38e-06	2.37e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HTR2A—hypertension	1.38e-06	2.37e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—C3—hypertension	1.38e-06	2.36e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ADCY5—hypertension	1.37e-06	2.34e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—FN1—hypertension	1.36e-06	2.33e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—F2—hypertension	1.36e-06	2.33e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PRKCB—hypertension	1.36e-06	2.33e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PRKCG—hypertension	1.36e-06	2.33e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HTR2A—hypertension	1.35e-06	2.32e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—C3—hypertension	1.35e-06	2.32e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ALB—hypertension	1.35e-06	2.31e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ITGB3—hypertension	1.35e-06	2.31e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PRKCA—hypertension	1.35e-06	2.31e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PDGFB—hypertension	1.34e-06	2.3e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—YWHAZ—hypertension	1.34e-06	2.29e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FGFR1—hypertension	1.33e-06	2.29e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOTCH1—hypertension	1.33e-06	2.28e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—POMC—hypertension	1.32e-06	2.27e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NGF—hypertension	1.32e-06	2.27e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SPP1—hypertension	1.32e-06	2.27e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—INS—hypertension	1.32e-06	2.26e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PDGFB—hypertension	1.32e-06	2.26e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CXCL8—hypertension	1.31e-06	2.26e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HIF1A—hypertension	1.31e-06	2.25e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FGFR1—hypertension	1.31e-06	2.24e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AGT—hypertension	1.31e-06	2.24e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MYC—hypertension	1.3e-06	2.23e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TGFB1—hypertension	1.3e-06	2.23e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCL2—hypertension	1.29e-06	2.22e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3R1—hypertension	1.29e-06	2.21e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—NOS3—hypertension	1.29e-06	2.21e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HIF1A—hypertension	1.29e-06	2.21e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CALM1—hypertension	1.29e-06	2.21e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCR5—hypertension	1.28e-06	2.2e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PRKCD—hypertension	1.28e-06	2.2e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AGT—hypertension	1.28e-06	2.2e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—LEP—hypertension	1.28e-06	2.2e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APOE—hypertension	1.28e-06	2.2e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IGF1—hypertension	1.27e-06	2.18e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—EGFR—hypertension	1.27e-06	2.18e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKT2—hypertension	1.27e-06	2.18e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CAV1—hypertension	1.27e-06	2.18e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APOA1—hypertension	1.27e-06	2.17e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—EGFR—hypertension	1.27e-06	2.17e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CALM1—hypertension	1.26e-06	2.17e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—LEP—hypertension	1.26e-06	2.16e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APOE—hypertension	1.26e-06	2.16e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HTR2A—hypertension	1.26e-06	2.16e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—KDR—hypertension	1.26e-06	2.15e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—C3—hypertension	1.26e-06	2.15e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CAV1—hypertension	1.25e-06	2.14e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APOA1—hypertension	1.24e-06	2.13e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—POMC—hypertension	1.24e-06	2.12e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KDR—hypertension	1.23e-06	2.11e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—INS—hypertension	1.23e-06	2.11e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PDGFB—hypertension	1.22e-06	2.1e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PPARG—hypertension	1.22e-06	2.09e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FGFR1—hypertension	1.22e-06	2.09e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCL2—hypertension	1.21e-06	2.07e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FN1—hypertension	1.21e-06	2.07e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—F2—hypertension	1.21e-06	2.07e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PRKCB—hypertension	1.21e-06	2.07e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SERPINE1—hypertension	1.21e-06	2.07e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—POMC—hypertension	1.2e-06	2.06e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HIF1A—hypertension	1.2e-06	2.05e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—INS—hypertension	1.19e-06	2.05e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AGT—hypertension	1.19e-06	2.05e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IGF1—hypertension	1.19e-06	2.04e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT2—hypertension	1.19e-06	2.04e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—AKT1—hypertension	1.19e-06	2.04e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PRKCB—hypertension	1.19e-06	2.03e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FN1—hypertension	1.19e-06	2.03e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—F2—hypertension	1.19e-06	2.03e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—EGFR—hypertension	1.18e-06	2.03e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOTCH1—hypertension	1.18e-06	2.03e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTGS2—hypertension	1.18e-06	2.02e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CALM1—hypertension	1.17e-06	2.01e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—FGF2—hypertension	1.17e-06	2.01e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOE—hypertension	1.17e-06	2e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—LEP—hypertension	1.17e-06	2e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RHOA—hypertension	1.17e-06	2e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOTCH1—hypertension	1.16e-06	1.99e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CAV1—hypertension	1.16e-06	1.99e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOA1—hypertension	1.16e-06	1.98e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NOS3—hypertension	1.15e-06	1.98e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3R1—hypertension	1.15e-06	1.98e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KDR—hypertension	1.15e-06	1.96e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SERPINE1—hypertension	1.13e-06	1.94e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—F2—hypertension	1.1e-06	1.89e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PRKCB—hypertension	1.1e-06	1.89e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FN1—hypertension	1.1e-06	1.89e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—POMC—hypertension	1.1e-06	1.89e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—INS—hypertension	1.1e-06	1.88e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ALB—hypertension	1.09e-06	1.88e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—FGF2—hypertension	1.09e-06	1.87e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RHOA—hypertension	1.09e-06	1.87e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RELA—hypertension	1.09e-06	1.86e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—POMC—hypertension	1.08e-06	1.85e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOTCH1—hypertension	1.08e-06	1.85e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3R1—hypertension	1.08e-06	1.85e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOS3—hypertension	1.08e-06	1.85e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCL2—hypertension	1.08e-06	1.85e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—INS—hypertension	1.07e-06	1.84e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TP53—hypertension	1.07e-06	1.83e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MTOR—hypertension	1.07e-06	1.83e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IGF1—hypertension	1.06e-06	1.82e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT2—hypertension	1.06e-06	1.82e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCL2—hypertension	1.06e-06	1.81e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—EGFR—hypertension	1.05e-06	1.81e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3R1—hypertension	1.05e-06	1.8e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—NOS3—hypertension	1.05e-06	1.8e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IGF1—hypertension	1.04e-06	1.78e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT2—hypertension	1.04e-06	1.78e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—EGFR—hypertension	1.03e-06	1.77e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTEN—hypertension	1.03e-06	1.76e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCL8—hypertension	1.02e-06	1.76e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RELA—hypertension	1.01e-06	1.74e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SERPINE1—hypertension	1.01e-06	1.73e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—POMC—hypertension	1e-06	1.72e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—INS—hypertension	9.99e-07	1.71e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MTOR—hypertension	9.95e-07	1.71e-05	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—AKT1—hypertension	9.89e-07	1.7e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SERPINE1—hypertension	9.87e-07	1.69e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCL2—hypertension	9.83e-07	1.68e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—EP300—hypertension	9.81e-07	1.68e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL6—hypertension	9.78e-07	1.68e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FGF2—hypertension	9.74e-07	1.67e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL6—hypertension	9.74e-07	1.67e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RHOA—hypertension	9.71e-07	1.66e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IGF1—hypertension	9.66e-07	1.66e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT2—hypertension	9.65e-07	1.66e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—EGFR—hypertension	9.61e-07	1.65e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3R1—hypertension	9.61e-07	1.65e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOS3—hypertension	9.61e-07	1.65e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTGS2—hypertension	9.58e-07	1.64e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCL8—hypertension	9.56e-07	1.64e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FGF2—hypertension	9.56e-07	1.64e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RHOA—hypertension	9.52e-07	1.63e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOS3—hypertension	9.43e-07	1.62e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3R1—hypertension	9.43e-07	1.62e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MMP9—hypertension	9.26e-07	1.59e-05	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—AKT1—hypertension	9.24e-07	1.58e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CDKN1A—hypertension	9.23e-07	1.58e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PTEN—hypertension	9.21e-07	1.58e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SERPINE1—hypertension	9.17e-07	1.57e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL6—hypertension	9.09e-07	1.56e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RELA—hypertension	9.04e-07	1.55e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—AKT1—hypertension	9.02e-07	1.55e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MAPK8—hypertension	9.01e-07	1.54e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—AKT1—hypertension	8.98e-07	1.54e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FGF2—hypertension	8.88e-07	1.52e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RELA—hypertension	8.87e-07	1.52e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MTOR—hypertension	8.87e-07	1.52e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RHOA—hypertension	8.85e-07	1.52e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EP300—hypertension	8.78e-07	1.51e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3R1—hypertension	8.76e-07	1.5e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOS3—hypertension	8.76e-07	1.5e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MTOR—hypertension	8.7e-07	1.49e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MMP9—hypertension	8.65e-07	1.48e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CDKN1A—hypertension	8.62e-07	1.48e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PTEN—hypertension	8.6e-07	1.47e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SRC—hypertension	8.54e-07	1.46e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCL8—hypertension	8.52e-07	1.46e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MAPK8—hypertension	8.41e-07	1.44e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—AKT1—hypertension	8.39e-07	1.44e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCL8—hypertension	8.36e-07	1.43e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTEN—hypertension	8.35e-07	1.43e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—VEGFA—hypertension	8.32e-07	1.43e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RELA—hypertension	8.24e-07	1.41e-05	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—AKT1—hypertension	8.23e-07	1.41e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EP300—hypertension	8.2e-07	1.41e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL6—hypertension	8.1e-07	1.39e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MTOR—hypertension	8.08e-07	1.39e-05	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—AKT1—hypertension	8.08e-07	1.39e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SRC—hypertension	7.98e-07	1.37e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—EP300—hypertension	7.97e-07	1.37e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL6—hypertension	7.95e-07	1.36e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCL8—hypertension	7.77e-07	1.33e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—VEGFA—hypertension	7.77e-07	1.33e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MMP9—hypertension	7.71e-07	1.32e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CDKN1A—hypertension	7.68e-07	1.32e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PTEN—hypertension	7.66e-07	1.31e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MYC—hypertension	7.65e-07	1.31e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TGFB1—hypertension	7.63e-07	1.31e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MMP9—hypertension	7.56e-07	1.3e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CDKN1A—hypertension	7.53e-07	1.29e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PTEN—hypertension	7.52e-07	1.29e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—AKT1—hypertension	7.5e-07	1.29e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MAPK8—hypertension	7.49e-07	1.29e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EGFR—hypertension	7.48e-07	1.28e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—AKT1—hypertension	7.47e-07	1.28e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL6—hypertension	7.39e-07	1.27e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MAPK8—hypertension	7.35e-07	1.26e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—AKT1—hypertension	7.33e-07	1.26e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EP300—hypertension	7.31e-07	1.25e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EP300—hypertension	7.17e-07	1.23e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MYC—hypertension	7.15e-07	1.23e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TGFB1—hypertension	7.13e-07	1.22e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SRC—hypertension	7.1e-07	1.22e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MMP9—hypertension	7.03e-07	1.2e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CDKN1A—hypertension	7e-07	1.2e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EGFR—hypertension	6.99e-07	1.2e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PTEN—hypertension	6.99e-07	1.2e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SRC—hypertension	6.97e-07	1.2e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—VEGFA—hypertension	6.92e-07	1.19e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MAPK8—hypertension	6.83e-07	1.17e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AKT1—hypertension	6.81e-07	1.17e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—VEGFA—hypertension	6.79e-07	1.16e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EP300—hypertension	6.66e-07	1.14e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SRC—hypertension	6.48e-07	1.11e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MYC—hypertension	6.37e-07	1.09e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TGFB1—hypertension	6.35e-07	1.09e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—VEGFA—hypertension	6.31e-07	1.08e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TP53—hypertension	6.28e-07	1.08e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MYC—hypertension	6.25e-07	1.07e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TGFB1—hypertension	6.23e-07	1.07e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGFR—hypertension	6.23e-07	1.07e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGFR—hypertension	6.11e-07	1.05e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AKT1—hypertension	5.93e-07	1.02e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TP53—hypertension	5.87e-07	1.01e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MYC—hypertension	5.8e-07	9.96e-06	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TGFB1—hypertension	5.79e-07	9.93e-06	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL6—hypertension	5.75e-07	9.86e-06	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGFR—hypertension	5.68e-07	9.74e-06	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL6—hypertension	5.37e-07	9.21e-06	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKT1—hypertension	5.31e-07	9.1e-06	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TP53—hypertension	5.23e-07	8.97e-06	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TP53—hypertension	5.13e-07	8.8e-06	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT1—hypertension	4.96e-07	8.5e-06	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AKT1—hypertension	4.81e-07	8.26e-06	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL6—hypertension	4.79e-07	8.21e-06	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TP53—hypertension	4.77e-07	8.18e-06	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL6—hypertension	4.7e-07	8.05e-06	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT1—hypertension	4.42e-07	7.57e-06	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL6—hypertension	4.36e-07	7.48e-06	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT1—hypertension	4.33e-07	7.43e-06	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT1—hypertension	4.03e-07	6.9e-06	CbGpPWpGaD
